Skip to main content
. 2021 Feb 5;10:593293. doi: 10.3389/fonc.2020.593293

Figure 2.

Figure 2

High expression of DDX11 is correlated with poor prognosis in HCC. (A, B) Patients with HCC in TCGA cohort were divided into DDX11high and DDX11low, according to the median expression of DDX11 mRNA. Kaplan-Meier survival analyses (log-rank test) were conducted to indicate the clinical value of DDX11 mRNA in overall (A) and disease-free (B) survivals. (C, D) The implication of DDX11 protein expression was determined in patients with HCC in SYSUCC cohort. The median IHC score of DDX11 in HCC tissues was used as the cut-off value to separate cases into groups of DDX11high and DDX11low. (E) The impact of DDX11 mRNA on overall survival (OS) and disease-free survival (DFS) was tested in TCGA cancers (Mantel–Cox test). Significant p values were indicated by red and blue frames.